Jun 10, 2026Confidence A
Product0 evidence links
Valink Therapeutics product scope reviewed
Valink Therapeutics public product source reviewed for category placement and current operating focus.
No source evidence matched to this event.Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Valink Therapeutics public product source reviewed for category placement and current operating focus.
No source evidence matched to this event.Valink Therapeutics public source reviewed for capital or strategic-status timeline signal.
No source evidence matched to this event.Valink Therapeutics official source reviewed for product scope, operating focus, and category placement.
Open sourceValink Therapeutics public capital or strategic-status source reviewed for stage and timeline signal.
Open source